GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1

Diabetologia

Volumn 59, Issue 5, 2016, Pages 1059-1069

  Xu, Fen ^a,b   Lin, Beisi ^a,b   Zheng, Xiaobin ^a,b   Chen, Zonglan ^a,b   Cao, Huanyi ^a,b   Xu, Haixia ^a,b   Liang, Hua ^a,b   Weng, Jianping ^a,b  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b Environmental Pollution Control and Remediation Technology   (China)

Author keywords

Adipocytes; Fatty acid oxidation; GLP 1; Lipolysis; Obesity; Sirtuin 1

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CARNITINE PALMITOYLTRANSFERASE I; CYTOCHROME C OXIDASE; EXENDIN 4; FAT DROPLET; GLYCEROL; HORMONE SENSITIVE LIPASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; MITOCHONDRIAL DNA; N [2 [3 (1 PIPERAZINYLMETHYL)IMIDAZO[2,1 B]THIAZOL 6 YL]PHENYL] 2 QUINOXALINECARBOXAMIDE; NICOTINAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SIRTUIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCOUPLING PROTEIN 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; PEPTIDE; VENOM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; COMPARATIVE STUDY; CONTROLLED STUDY; DEACETYLATION; DIET INDUCED OBESITY; EMBRYO; ENZYME ACTIVITY; FAT MASS; FATTY ACID OXIDATION; FOOD INTAKE; GENETIC TRANSFECTION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; GLYCEROL BLOOD LEVEL; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID DIET; LIPID OXIDATION; LIPOLYSIS; MALE; METABOLIC DISORDER; MITOCHONDRIAL BIOGENESIS; MOUSE; NONHUMAN; OBESITY; OXIDATION; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN EXPRESSION; RNA INTERFERENCE; UPREGULATION; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE; ADVERSE EFFECTS; AGONISTS; ANIMAL; BODY WEIGHT; C57BL MOUSE; DRUG EFFECTS; GENETICS; LIPID METABOLISM; METABOLISM; MOUSE MUTANT; MUTANT MOUSE STRAIN;

ADIPOSE TISSUE, WHITE; ANIMALS; BODY WEIGHT; DIET, HIGH-FAT; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; LIPID METABOLISM; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, OBESE; PEPTIDES; SIRTUIN 1; VENOMS;

EID: 84962977228     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-016-3896-5     Document Type: Article

References (40)

1. Twig G, Afek A, Derazne E et al (2014) Diabetes risk among overweight and obese metabolically healthy young adults. Diabetes Care 37:2989–2995
2. Astrup A, Rossner S, Van Gaal L et al (2009) Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 374:1606–1616
3. DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD (2005) Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care 28:1092–1100
4. Kanoski SE, Fortin SM, Arnold M, Grill HJ, Hayes MR (2011) Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4. Endocrinology 152:3103–3112
5. Wettergren A, Wojdemann M, Holst JJ (1998) Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow. Am J Physiol 275:G984–G992
6. Nielsen TS, Jessen N, Jorgensen JO, Moller N, Lund S (2014) Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease. J Mol Endocrinol 52:R199–R222
7. Wilson-Fritch L, Nicoloro S, Chouinard M et al (2004) Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest 114:1281–1289
8. Yin X, Lanza IR, Swain JM, Sarr MG, Nair KS, Jensen MD (2014) Adipocyte mitochondrial function is reduced in human obesity independent of fat cell size. J Clin Endocrinol Metab 99:E209–E216
9. Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84:277–359
10. Bartelt A, Heeren J (2014) Adipose tissue browning and metabolic health. Nat Rev Endocrinol 10:24–36
11. Wu J, Cohen P, Spiegelman BM (2013) Adaptive thermogenesis in adipocytes: is beige the new brown? Genes Dev 27:234–250
12. Feige JN, Lagouge M, Canto C et al (2008) Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab 8:347–358
13. Milne JC, Lambert PD, Schenk S et al (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450:712–716
14. Chakrabarti P, English T, Karki S et al (2011) SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL. J Lipid Res 52:1693–1701
15. Xu C, Bai B, Fan P et al (2013) Selective overexpression of human SIRT1 in adipose tissue enhances energy homeostasis and prevents the deterioration of insulin sensitivity with ageing in mice. Am J Transl Res 5:412–426
16. +/- mice: a role of lipid mobilization and inflammation. Endocrinology 151(6):2504–2514
17. Cheng HL, Mostoslavsky R, Saito S et al (2003) Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci U S A 100(19):10794–10799
18. Xu F, Li Z, Zheng X et al (2014) SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis. Diabetes 63:3637–3646
19. Anil KK, Marita AR (2000) Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocytes. Br J Pharmacol 130:351–358
20. Jendle J, Nauck MA, Matthews DR et al (2009) Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue. Diabetes Obes Metab 11:1163–1172
21. Richard JE, Anderberg RH, Goteson A, Gribble FM, Reimann F, Skibicka KP (2015) Activation of the GLP-1 receptors in the nucleus of the solitary tract reduces food reward behavior and targets the mesolimbic system. PLoS One 10, e119034
22. van Bloemendaal L, IJzerman RG, Ten KJ et al (2014) GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans. Diabetes 63:4186–4196
23. Wei Q, Li L, Chen JA, Wang SH, Sun ZL (2015) Exendin-4 improves thermogenic capacity by regulating fat metabolism on brown adipose tissue in mice with diet-induced obesity. Ann Clin Lab Sci 45:158–165
24. Vendrell J, El BR, Peral B et al (2011) Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance. Endocrinology 152:4072–4079
25. Bertin E, Arner P, Bolinder J, Hagstrom-Toft E (2001) Action of glucagon and glucagon-like peptide-1-(7-36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo. J Clin Endocrinol Metab 86:1229–1234
26. Bi Y, Zhang B, Xu W et al (2014) Effects of exenatide, insulin, and pioglitazone on liver fat content and body fat distributions in drug-naive subjects with type 2 diabetes. Acta Diabetol 51:865–873
27. Gaidhu MP, Fediuc S, Anthony NM et al (2009) Prolonged AICAR-induced AMP-kinase activation promotes energy dissipation in white adipocytes: novel mechanisms integrating HSL and ATGL. J Lipid Res 50:704–715
28. Ceddia RB (2013) The role of AMP-activated protein kinase in regulating white adipose tissue metabolism. Mol Cell Endocrinol 366:194–203
29. Um JH, Park SJ, Kang H et al (2010) AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 59:554–563
30. Jun HJ, Joshi Y, Patil Y, Noland RC, Chang JS (2014) NT-PGC-1alpha activation attenuates high-fat diet-induced obesity by enhancing brown fat thermogenesis and adipose tissue oxidative metabolism. Diabetes 63:3615–3625
31. Qiang L, Wang L, Kon N et al (2012) Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Ppargamma. Cell 150:620–632
32. Barbatelli G, Murano I, Madsen L et al (2010) The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. Am J Physiol Endocrinol Metab 298:E1244–E1253
33. Andrade JM, Frade AC, Guimaraes JB et al (2014) Resveratrol increases brown adipose tissue thermogenesis markers by increasing SIRT1 and energy expenditure and decreasing fat accumulation in adipose tissue of mice fed a standard diet. Eur J Nutr 53:1503–1510
34. Mercader J, Palou A, Bonet ML (2011) Resveratrol enhances fatty acid oxidation capacity and reduces resistin and retinol-binding protein 4 expression in white adipocytes. J Nutr Biochem 22:828–834
35. Boschmann M, Engeli S, Dobberstein K et al (2009) Dipeptidyl-peptidase-IV inhibition augments postprandial lipid mobilization and oxidation in type 2 diabetic patients. J Clin Endocrinol Metab 94:846–852
36. Nogueiras R, Perez-Tilve D, Veyrat-Durebex C et al (2009) Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity. J Neurosci 29:5916–5925
37. Beiroa D, Imbernon M, Gallego R et al (2014) GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK. Diabetes 63:3346–3358
38. Kooijman S, Wang Y, Parlevliet ET et al (2015) Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice. Diabetologia 58:2637–2646
39. van Bloemendaal L, Ten Kulve JS, la Fleur SE et al (2014) Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS. J Endocrinol 221(1):T1–T16
40. Heppner KM, Marks S, Holland J et al (2015) Contribution of brown adipose tissue activity to the control of energy balance by GLP-1 receptor signalling in mice. Diabetologia 58:2124–2132